Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Milestone Scientific (MLSS) Gross Profit (2016 - 2025)

Milestone Scientific (MLSS) has disclosed Gross Profit for 16 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Gross Profit fell 0.62% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.4 million through Dec 2025, changed 0.42% year-over-year, with the annual reading at $6.4 million for FY2025, 0.42% changed from the prior year.
  • Gross Profit hit $1.5 million in Q4 2025 for Milestone Scientific, down from $1.6 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $1.9 million in Q2 2023 to a low of $680648.0 in Q2 2022.
  • Historically, Gross Profit has averaged $1.5 million across 5 years, with a median of $1.6 million in 2024.
  • Biggest five-year swings in Gross Profit: surged 1122.11% in 2021 and later crashed 50.29% in 2022.
  • Year by year, Gross Profit stood at $1.8 million in 2021, then crashed by 39.05% to $1.1 million in 2022, then skyrocketed by 39.22% to $1.5 million in 2023, then rose by 0.04% to $1.5 million in 2024, then dropped by 0.62% to $1.5 million in 2025.
  • Business Quant data shows Gross Profit for MLSS at $1.5 million in Q4 2025, $1.6 million in Q3 2025, and $1.6 million in Q2 2025.